Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Torre-Alonso

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
British Journal of Rheumatology|August 1, 1991
Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patientsJ C Torre Alonso, A Rodriguez Perez, J M Arribas Castrillo, et al.
Rheumatology (Oxford, England)|August 25, 2005
Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre studyE Collantes-Estevez, M C Muñoz-Villanueva, P Zarco, et al.
The Journal of Rheumatology|June 21, 2001
TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patientsS González, J C Torre-Alonso, J Martínez-Borra, et al.
Arthritis and Rheumatism|May 14, 1999
The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasisS Gonzalez, J Martinez-Borra, J C Torre-Alonso, et al.
Rheumatology (Oxford, England)|May 6, 2003
Psoriasis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-CJ Martínez-Borra, S González, J Santos-Juanes, et al.
Annals of the Rheumatic Diseases|December 3, 2003
Infliximab in refractory spondyloarthropathies: a multicentre 38 week open studyE Collantes-Estévez, M C Muñoz-Villanueva, J D Cañete-Crespillo, et al.
Clinical and Experimental Rheumatology|December 24, 2010
Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damageR Almodóvar, L Carmona, P Zarco, et al.
Rheumatology (Oxford, England)|May 29, 2007
Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended reportE Collantes, P Zarco, E Muñoz, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
British Journal of Rheumatology|August 1, 1991
Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patientsJ C Torre Alonso, A Rodriguez Perez, J M Arribas Castrillo, et al.
Rheumatology (Oxford, England)|August 25, 2005
Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre studyE Collantes-Estevez, M C Muñoz-Villanueva, P Zarco, et al.
The Journal of Rheumatology|June 21, 2001
TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patientsS González, J C Torre-Alonso, J Martínez-Borra, et al.
Arthritis and Rheumatism|May 14, 1999
The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasisS Gonzalez, J Martinez-Borra, J C Torre-Alonso, et al.
Rheumatology (Oxford, England)|May 6, 2003
Psoriasis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-CJ Martínez-Borra, S González, J Santos-Juanes, et al.
Annals of the Rheumatic Diseases|December 3, 2003
Infliximab in refractory spondyloarthropathies: a multicentre 38 week open studyE Collantes-Estévez, M C Muñoz-Villanueva, J D Cañete-Crespillo, et al.
Clinical and Experimental Rheumatology|December 24, 2010
Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damageR Almodóvar, L Carmona, P Zarco, et al.
Rheumatology (Oxford, England)|May 29, 2007
Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended reportE Collantes, P Zarco, E Muñoz, et al.
Pageof 2